🇺🇸 FDA
Patent

US 7758876

Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides

granted A61KA61K2039/55561A61K2039/57

Quick answer

US patent 7758876 (Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jul 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K2039/55561, A61K2039/57, A61K31/711, A61K31/7125